The University Clinical Center of the Republika Srpska is a medical centre located in Banja Luka, Bosnia and Herzegovina. It serves as the main medical centre for both Banja Luka and Republika Srpska.

There are 1,246 (2016) beds in University Clinical Centre of the Republic of Srpska.

During the past decade, University Clinical Centre of the Republic of Srpska conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 28 clinical trials were completed, i.e. on average, 75.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 16 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Clinical Centre of the Republic of Srpska" #1 sponsor was "Hoffmann-La Roche" with 21 trials, followed by "Celgene" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Takeda" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Centre of the Republic of Srpska" #1 collaborator was "BioGene Pharmaceutical Inc." with 1 trials as a collaborator, "Churchill Hospital" with 1 trials as a collaborator, "Clinical Center Kragujevac" with 1 trials as a collaborator, "Clinical Center Nis, Nis" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University Clinical Centre of the Republic of Srpska" are "Crohn's Disease" (6 trials), "Breast Cancer" (3 trials), "Colitis, Ulcerative" (3 trials), "Crohn Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "University Clinical Centre of the Republic of Srpska" in a lesser frequency.

Most popular intervention types in "University Clinical Centre of the Republic of Srpska" are "Drug" (47 trials), "Other" (6 trials), "Biological" (5 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Atezolizumab" (5 trials), "Cyclophosphamide" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in "University Clinical Centre of the Republic of Srpska" are 47 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University Clinical Centre of the Republic of Srpska". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in University Clinical Centre of the Republic of Srpska, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University Clinical Centre of the Republic of Srpska, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".